Czechia – Radioactive materials – Radiofarmaka 177Lu-PSMA

The subject of the contract is the continuous supply of the radiopharmaceutical 177Lu-PSMA, (177Lu) vipivotid tetraxetan inj. for human therapy of patients with prostate carcinoma, in the form of an injectable solution (for i.v. administration) to the reference time from the order, for a period of 4 years according to the current needs of the contracting authority and the related services, i.e. supply including delivery to the contracting authority's workplace.